Variable Susceptibility to Gallium Compounds of Major Cystic Fibrosis Pathogens

[Image: see text] The decreasing efficacy of existing antibiotics against pulmonary pathogens that affect cystic fibrosis (CF) patients calls for the development of novel antimicrobials. Iron uptake and metabolism are vital processes for bacteria, hence potential therapeutic targets. Gallium [Ga(III...

Descripción completa

Detalles Bibliográficos
Autores principales: Visaggio, Daniela, Frangipani, Emanuela, Hijazi, Sarah, Pirolo, Mattia, Leoni, Livia, Rampioni, Giordano, Imperi, Francesco, Bernstein, Lawrence, Sorrentino, Raffaella, Ungaro, Francesca, Visca, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762661/
https://www.ncbi.nlm.nih.gov/pubmed/34965085
http://dx.doi.org/10.1021/acsinfecdis.1c00409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762661/
https://www.ncbi.nlm.nih.gov/pubmed/34965085
http://dx.doi.org/10.1021/acsinfecdis.1c00409

Ejemplares similares